Patents Assigned to UNIVERSITÉ PIERRE ET MARIE CURIE
  • Patent number: 8802815
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: August 12, 2014
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Patent number: 8803460
    Abstract: A device, having first and second motor units, for generating a torque on an output member in response to a torque setpoint. The first motor unit includes at least one motor of a first power, or small motor, having a shaft to which the output member is connected. The second motor unit includes at least one motor of a second power higher than the first power, or large motor, having a shaft rotationally connected to the output member via viscous coupler, and computer programmed, in response to a torque setpoint, to power the second motor unit so that the viscous coupler provides a viscous torque conforming to the torque setpoint. Further, in parallel with this, the first motor unit is powered so that it produces the additional torque between the torque setpoint and the viscous torque until the viscous torque reaches the value of the torque setpoint.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: August 12, 2014
    Assignees: Universite Pierre et Marie Curie (Paris 6), Centre National de la Recherche Scientifique
    Inventors: Guillaume Millet, Vincent Hayward, Dogan Sinan Haliyo, Stéphane Regnier
  • Patent number: 8798341
    Abstract: A method for reading an emulsion (3) including droplets and a continuous phase surrounding the droplets, the method includes: two-dimensional scanning of the emulsion (3), and construction of a two-dimensional image of the emulsion (3) based on the scanning. Preferably, the droplets do not move during scanning, for example by solidifying the continuous phase or by using a two-dimensional compact or semi-compact network of droplets. The method can further include time-based monitoring of a chemical or biological reaction taking place in at least one of the droplets. A device implementing this method is also described. The method is applicable for the detection and/or sorting of microdroplets performing the role of microreactors or containing specific cells or molecules, in fields such as gene expression or diagnosis.
    Type: Grant
    Filed: July 13, 2009
    Date of Patent: August 5, 2014
    Assignees: Universite Pierre et Marie Curie (Paris 6), Centre National de la Recherche Scientifique, Universite Paris Diderot-Paris 7
    Inventors: Jean Baudry, Julien Sylvestre, Jerome Bibette, Laurent Boitard, Nicolas Bremond
  • Publication number: 20140212931
    Abstract: The present invention concerns iodoperoxidases from Zobellia galactanivorans, isolated nucleic acids encoding same, as well as methods for preparing these enzymes. Moreover, the invention is also directed to the use of such iodoperoxidases in a wide range of industrial, pharmaceutical, medical, cosmetics, and ecological applications, as well as in the food industry.
    Type: Application
    Filed: July 5, 2012
    Publication date: July 31, 2014
    Applicants: Universite Pierre et Marie Curie (Paris 6), Centre National de la Recherche Scientifique (CNRS)
    Inventors: Catherine Leblanc, Ludovic Delage, Gurvan Michel, Etienne Rebuffet, Mirjam Czjzek, Philippe Potin
  • Publication number: 20140207150
    Abstract: The invention relates to an endoscopic instrument (1) having an elongate body with a distal end (4) designed to be introduced into the body of the patient so as to come into proximity with an internal organ, the distal end carrying a tool (7) for intervention on the internal organ. The endoscopic instrument has a fool (10) rigidly connected to the distal end and designed to bear on the internal organ, and also controllable means (13) for conferring movements on the tool, at least in directions transverse to a longitudinal axis (X) of the distal end of the endoscopic instrument, when the foot is bearing against the internal organ.
    Type: Application
    Filed: June 25, 2012
    Publication date: July 24, 2014
    Applicants: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ENDOCONTROL, MAUNA KEA TECHNOLOGIES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Benoît Rosa, Benoît Herman, Jérôme Szewczyk, Guillaume Morel, Clément Vidal, Patrick Henri, François Lacombe, Jérôme Lopez
  • Patent number: 8774938
    Abstract: The invention relates to an implant which includes, in order to electrically stimulate a nerve structure, in particular the retina, an electrically insulating substrate (1), a array of recesses (2) formed in an upper surface of the substrate, stimulation electrodes (3) arranged at the bottom of the recesses, and an electrically conductive layer forming a ground plane (4) at the upper portion of the recesses. The sizes of the recesses and of the electrodes of the implant are such that the spatial selectivity of the stimulation current applied to the nerve structure is maximized.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: July 8, 2014
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Henri Lorach, Milan Djilas, Blaise Yvert, Philippe Bergonzo, Gaelle Lissorgues, Lionel Rousseau, Ryad Benjamin Benosman, Serge Picaud, Jose Sahel, Siohoi Ieng
  • Publication number: 20140154289
    Abstract: The present invention relates to novel compositions and methods for immunizing a host against malaria using a Plasmodium parasite genetically attenuated via the inactivation of the function of the hmgb2 gene.
    Type: Application
    Filed: July 19, 2012
    Publication date: June 5, 2014
    Applicants: INSTITUT PASTEUR, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Catherine Vaquero, Sylvie Briquet, Nadou Essenia Lawson-Hogban, Salaheddine Mecheri, Robert Menard
  • Publication number: 20140148480
    Abstract: A compound of formula (I-1) wherein n equals 0 or 1, Z represents O or S, R1 represents one group chosen among the group consisting of hydrogen, C1-C7 alkyl, substituted, or not, by a halogen, a hydroxyl or a —O—R12 group, wherein R12 is a C1-C7 alkyl, a group —CH2—O—CO—R5 wherein R5 is chosen among a hydrogen atom and a C1-C7 alkyl, substituted or not by at least one halogen, a group —O—R13, wherein R13 is chosen among hydrogen and a C1-C7 alkyl, an amine or a —CH2— amine, R?1 represents a group chosen among hydrogen and —O—R14, wherein R14 is chosen among hydrogen and a C1-C7 alkyl, and R2 is chosen among the group consisting of a C1-C7 alkyl, a C3-C6 cycloalkyl, an aryl group, and an heteroaryl group for the treatment of pathologies involving excess activity of at least one member of the kallikrein family.
    Type: Application
    Filed: January 15, 2014
    Publication date: May 29, 2014
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Michele REBOUD-RAVAUX, Chahrazade YERROUM-EL AMRI, Xiao TAN, Lixian QIN, Maurice PAGANO, Alain HOVNANIAN, Laetitia FURIO, Bernard PIROTTE
  • Patent number: 8733347
    Abstract: A device for detecting the improper adjustment of a ventilatory support machine used on a mammal. The device (12) includes measuring elements (40) for taking a measurement, as a function of time, of a neurophysiological signal involved in the respiratory process of the mammal for at least two successive breathing cycles, each breathing cycle comprising a respiratory initiation time; an input for receiving a respiratory initiation signal (to) which is different from the neurophysiological signal; elements (42) for processing the neurophysiological signals, which are configured to process the neurophysiological signals for each respiratory initiation time over a period of time starting from the respiratory initiation time; and elements (44) for detecting an improper adjustment of the ventilator using the processed signals.
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: May 27, 2014
    Assignee: Universite Pierre et Marie Curie-Paris VI
    Inventors: Thomas Similowski, Mathieu Raux, Christian Straus, Patrick Ray
  • Publication number: 20140118811
    Abstract: A method and a system is provided for configuring a device for correcting the effect of a medium on a light signal having propagated through the medium, the device including at least one optical element whose phase profiles are individually adjustable. The configuring system and method include propagating a reference signal and a disordered signal obtained at the output of the medium through the correcting device. An interference parameter is measured and optimized by modifying the phase profile of each of the optical elements of the correcting device. A method and a system is also provided for correcting the effect of a medium on a light signal having propagated through the medium.
    Type: Application
    Filed: December 21, 2011
    Publication date: May 1, 2014
    Applicants: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), AUSTRALIAN NATIONAL UNIVERSITY, ECOLE NORMALE SUPERIEURE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Jean-François Morizur, Hans Bachor, Nicolas Treps
  • Publication number: 20140113366
    Abstract: The invention relates to a microfluidic system for controlling a card for the concentration of molecules capable of stimulating a target, for example formed by an assembly of living cells, characterized in that the system comprises a microfluidic device (1) comprising: n?1 microfluidic channel(s) (4, 40), the or each channel being provided with at least one inlet orifice for at least one fluid and with at least one outlet orifice for this fluid; n?2 openings (47, 470) formed in the microfluidic channel or distributed in the various microfluidic channels, said openings being arranged in one and the same plane so that they form a network having at least one dimension in this plane, the numbers n of microfluidic channel(s) and n of openings being linked by the relationship (I) with 1?i?n and n the number of openings for the channel c; at least one microporous membrane (5) covering the network of openings, the target being intended to be positioned on the side of the membrane which is opposite the microfluidic ch
    Type: Application
    Filed: April 20, 2012
    Publication date: April 24, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS, ECOLE NORMALE SUPERIEURE, Universite de Bordeaux Segalen, FONDS DE L'ESPCI-GEORGES CHARPAK, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Maxime Dahan, Mathieu Morel, Jean-Christophe Galas, Vincent Studer, Denis Bartolo
  • Publication number: 20140106436
    Abstract: The invention relates to the use of at least one chelating agent, including an iron chelating agent, in order to stimulate the growth of magnetotactic bacteria.
    Type: Application
    Filed: May 4, 2012
    Publication date: April 17, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Edouard Alphandery, Imène Chebbi
  • Publication number: 20140107186
    Abstract: An isolated linear nucleic acid molecule comprising in this order: a first adeno-associated virus (AAV) inverted terminal repeat (ITR), a nucleotide sequence of interest and a second AAV ITR, wherein said nucleic acid molecule is devoid of AAV capsid protein coding sequences. The said nucleic acid molecule can be applied to a host at repetition without eliciting an immune response. Methods for producing and purifying this nucleic acid molecule, and use of the same for therapeutic purposes are also provided.
    Type: Application
    Filed: March 12, 2012
    Publication date: April 17, 2014
    Applicants: ASSOCIATION INSTITUT DE MYOLOGIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Luis Garcia, Cyriaque Beley, Thomas Voit, Robert Michael Kotin
  • Patent number: 8685662
    Abstract: The present invention pertains to a method for in vitro prognosticating and/or diagnosing cerebral cerebral malaria, wherein said method comprises a step of detecting non-erythroid spectrin or fragments thereof, and/or antibodies directed against non-erythroid spectrin, in a biological sample. Reagents and kits for performing this method are also disclosed.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: April 1, 2014
    Assignees: Institut Pasteur, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Sylviane Pied, Vincent Guiyedi, Pierre-André Cazenave, Maryvonne Kombila, Youri Chanseaud
  • Publication number: 20140080206
    Abstract: The invention relates to a microfluidic system for controlling a concentration profile of molecules capable of stimulating a target, for example formed by an assembly of living cells, this system comprising: -a microfluidic device (1) comprising at least one microfluidic channel (4) equipped with at least one inlet orifice (21) and with at least one outlet orifice (22) for at least one fluid; -at least one means for supplying the microfluidic channel (4) with at least one fluid comprising molecules capable of stimulating the target; -at least one chamber (8) or another microfluidic channel comprising a base (6) intended to receive the target; and -at least one microporous membrane (5) separating the chamber (8) or the other microfluidic channel from the microfluidic channel (4), said microporous membrane (5) being positioned away from the base (6) so that when the supply means provides the microfludic channel (4) with said at least one fluid flowing in laminar flow in contact with the microporous membrane (5)
    Type: Application
    Filed: March 2, 2012
    Publication date: March 20, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6), ECOLE NORMALE SUPÉRIEURE
    Inventors: Maxime Dahan, Mathieu Morel, Jean-Christophe Galas, Vincent Studer, Denis Bartolo
  • Patent number: 8673612
    Abstract: The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: March 18, 2014
    Assignee: L'Universite Pierre et Marie Curie
    Inventors: David Klatzmann, Jean-Loup Salzmann, Bertrand Bellier, Charlotte Frisen, François-Loïc Cosset
  • Publication number: 20140073916
    Abstract: The invention relates to a device for assisting in detecting anatomical features of at least a portion of a tissue, in particular a retinal tissue, the device comprising means for acquiring images of said portion using optical coherence tomography (OCT), which are taken at separate angles of incidence, and detection means for detecting, in a single area of the portion studied, at least one pattern having at least one feature that varies from one image to another, the pattern being attributable to the presence of anatomical features. The invention likewise relates to a method for assisting in detecting anatomical features of at least a portion of a tissue.
    Type: Application
    Filed: April 10, 2012
    Publication date: March 13, 2014
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Michel Paques, Sarah Mrejen
  • Publication number: 20140069865
    Abstract: This method comprises bringing drops to be separated into contact with an interface (40) suitable for allowing an osmotic equilibrium between the content of each drop to be separated. The method comprises an osmotic flow between the drops (20A) of the first group of drops through the interface (40) in order to modify the density of each drop (20A) of the first group of drops and the separation of the drops (20A, 20B) according to the density thereof or a combination of the density and the volume in order to isolate the drops (20A) of the first group of drops from the drops (20B) of a second group of drops.
    Type: Application
    Filed: March 21, 2012
    Publication date: March 13, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.), UNIVERSITE PARIS DIDEROT-PARIS 7, ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Gaël Yvert, Jérôme Bibette, Jean-Marie Baudry, Laurent Boitard, Nicolas Bremond, Denis Cottinet
  • Patent number: 8669089
    Abstract: The present invention notably relates to ulvan lyases, to nucleic acid sequences coding for these ulvan lyases, to vectors comprising these coding sequences, to a method of manufacturing these ulvan lyases, as well as to a method of degrading ulvans using these ulvan lyases and applicable applications to the degradation products of the ulvans. The ulvan lyases of the present invention, or ulvanolytic protein, are notably defined as proteins of 30 or 46 kD comprising the following four sequences in their peptide sequence: PNDPNLK, LLEVGNTGTFGSTGS, DLANPDNV and WNLPE.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: March 11, 2014
    Assignees: Centre National de la Recherche Scientifique-CNRS, Centre d'Etude et de Valorisation des Algues-CEVA, Universite Pierre et Marie Curie
    Inventors: William Helbert, Pi Nyvall-Collen, Yannick Lerat, Jean-François Sassi
  • Patent number: 8669106
    Abstract: The invention provides, among other things, methods and systems for expanding CD133+ cells. The invention further provides methods and systems for increasing the blood flow to an ischemic tissue in a subject in need thereof, such as to ischemic myocardium. The invention further provides methods and systems for directing differentiation of expanded CD133+ cells. The invention further provides methods and systems for treating a subject with differentiated cells in a subject in need thereof.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: March 11, 2014
    Assignees: Arteriocyte Inc., Universite Pierre ET Marie Curie (Paris VI)
    Inventors: Ramasamy Sakthivel, Donald J. Brown, Hai-Quan Mao, Luc Douay, Vincent J. Pompili, Kevin McIntosh, Hiranmoy Das, Yukang Zhao